128 related articles for article (PubMed ID: 31071370)
1. Cationic block amphiphiles show anti-mitochondrial activity in multi-drug resistant breast cancer cells.
Czupiel PP; Delplace V; Shoichet MS
J Control Release; 2019 Jul; 305():210-219. PubMed ID: 31071370
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle delivery of a pH-sensitive prodrug of doxorubicin and a mitochondrial targeting VES-H
Czupiel P; Delplace V; Shoichet M
Sci Rep; 2020 May; 10(1):8726. PubMed ID: 32457422
[TBL] [Abstract][Full Text] [Related]
3. Selective phenylalanine to proline substitution for improved antimicrobial and anticancer activities of peptides designed on phenylalanine heptad repeat.
Tripathi AK; Kumari T; Tandon A; Sayeed M; Afshan T; Kathuria M; Shukla PK; Mitra K; Ghosh JK
Acta Biomater; 2017 Jul; 57():170-186. PubMed ID: 28483698
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel aliphatic acid-conjugated antimicrobial peptides as potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability.
Zhang B; Gu H; Shi W; Li H; Ma G; Chen X; Qian H; Lin H; Huang W; Ge L
Amino Acids; 2017 Nov; 49(11):1831-1841. PubMed ID: 28831625
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of SA12, a novel peptide, on SKBr-3 breast cancer cells via the mitochondrial apoptosis pathway.
Yang L; Cui Y; Shen J; Lin F; Wang X; Long M; Wei J; Zhang H
Drug Des Devel Ther; 2015; 9():1319-30. PubMed ID: 25767377
[TBL] [Abstract][Full Text] [Related]
6. Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment.
Assanhou AG; Li W; Zhang L; Xue L; Kong L; Sun H; Mo R; Zhang C
Biomaterials; 2015 Dec; 73():284-95. PubMed ID: 26426537
[TBL] [Abstract][Full Text] [Related]
7. New derivatives of lupane triterpenoids disturb breast cancer mitochondria and induce cell death.
Serafim TL; Carvalho FS; Bernardo TC; Pereira GC; Perkins E; Holy J; Krasutsky DA; Kolomitsyna ON; Krasutsky PA; Oliveira PJ
Bioorg Med Chem; 2014 Nov; 22(21):6270-87. PubMed ID: 25245673
[TBL] [Abstract][Full Text] [Related]
8. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
[TBL] [Abstract][Full Text] [Related]
9. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer.
Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J
Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597
[TBL] [Abstract][Full Text] [Related]
10. α-Tocopherol-ascorbic acid hybrid antioxidant based cationic amphiphile for gene delivery: Design, synthesis and transfection.
Muripiti V; Brijesh L; Rachamalla HK; Marepally SK; Banerjee R; Patri SV
Bioorg Chem; 2019 Feb; 82():178-191. PubMed ID: 30326400
[TBL] [Abstract][Full Text] [Related]
11. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Apoptotic New Quinazolinone-Based Compound and Identification of its Underlying Mitochondrial Signalling Pathway in Breast Cancer Cells.
Zahedifard M; Faraj FL; Paydar M; Looi CY; Hasandarvish P; Hajrezaie M; Kamalidehghan B; Majid NA; Khalifa SA; Ali HM; Abdulla MA; El-Seedi HR
Curr Pharm Des; 2015; 21(23):3417-26. PubMed ID: 25808938
[TBL] [Abstract][Full Text] [Related]
13. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts.
Hilchie AL; Doucette CD; Pinto DM; Patrzykat A; Douglas S; Hoskin DW
Breast Cancer Res; 2011 Oct; 13(5):R102. PubMed ID: 22023734
[TBL] [Abstract][Full Text] [Related]
14. Multivalent display of pendant pro-apoptotic peptides increases cytotoxic activity.
Chu DS; Bocek MJ; Shi J; Ta A; Ngambenjawong C; Rostomily RC; Pun SH
J Control Release; 2015 May; 205():155-61. PubMed ID: 25596326
[TBL] [Abstract][Full Text] [Related]
15. Engineered apoptosis-inducing peptides with enhanced mitochondrial localization and potency.
Horton KL; Kelley SO
J Med Chem; 2009 May; 52(10):3293-9. PubMed ID: 19397319
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel peptides based on antimicrobial peptides as potential agents with antitumor and multidrug resistance-reversing activities.
Zhang B; Shi W; Li J; Liao C; Yang L; Huang W; Qian H
Chem Biol Drug Des; 2017 Nov; 90(5):972-980. PubMed ID: 28524273
[TBL] [Abstract][Full Text] [Related]
17. The α-tocopherol derivative ESeroS-GS induces cell death and inhibits cell motility of breast cancer cells through the regulation of energy metabolism.
Zhao L; Zhao X; Zhao K; Wei P; Fang Y; Zhang F; Zhang B; Ogata K; Mori A; Wei T
Eur J Pharmacol; 2014 Dec; 745():98-107. PubMed ID: 25446928
[TBL] [Abstract][Full Text] [Related]
18. Induction of Mitochondrial Cell Death and Reversal of Anticancer Drug Resistance via Nanocarriers Composed of a Triphenylphosphonium Derivative of Tocopheryl Polyethylene Glycol Succinate.
Singh Y; Viswanadham KKDR; Pawar VK; Meher J; Jajoriya AK; Omer A; Jaiswal S; Dewangan J; Bora HK; Singh P; Rath SK; Lal J; Mishra DP; Chourasia MK
Mol Pharm; 2019 Sep; 16(9):3744-3759. PubMed ID: 31441308
[TBL] [Abstract][Full Text] [Related]
19. Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response.
Jiang L; Li L; He X; Yi Q; He B; Cao J; Pan W; Gu Z
Biomaterials; 2015 Jun; 52():126-39. PubMed ID: 25818419
[TBL] [Abstract][Full Text] [Related]
20. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
